Literature DB >> 14680319

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

Nicolette K Janzen1, Hyung L Kim, Robert A Figlin, Arie S Belldegrun.   

Abstract

Surveillance after surgery for RCC is important because approximately 50% of these patients will develop a disease recurrence, two thirds of who will recur within the first year. Although the prognosis is generally poor in these patients, some may respond favorably to immunotherapy. The small subset of patients who develop solitary metastases has the greatest chance to achieve long-term survival. Aggressive surgical resection is an integral part of this success. Proposed surveillance protocols using a stage-based approach or an integrated approach combining stage with other important prognostic factors attempt to provide a rational approach to identifying treatable recurrences while minimizing unnecessary examinations and patient anxiety. However, strict adherence to follow-up guidelines may not be appropriate for all patients. Factors including patient comorbidities and patient willingness to pursue aggressive management in the event of recurrence may alter the follow-up for each individual.

Entities:  

Mesh:

Year:  2003        PMID: 14680319     DOI: 10.1016/s0094-0143(03)00056-9

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  231 in total

1.  A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma.

Authors:  Natsuko Suwaki; Elsa Vanhecke; Katelyn M Atkins; Manuela Graf; Katherine Swabey; Paul Huang; Peter Schraml; Holger Moch; Amy Mulick Cassidy; Daniel Brewer; Bissan Al-Lazikani; Paul Workman; Johann De-Bono; Stan B Kaye; James Larkin; Martin E Gore; Charles L Sawyers; Peter Nelson; Tomasz M Beer; Hao Geng; Lina Gao; David Z Qian; Joshi J Alumkal; Gary Thomas; George V Thomas
Journal:  Sci Transl Med       Date:  2011-06-01       Impact factor: 17.956

2.  Pancreatic metastases from renal cell carcinoma: the state of the art.

Authors:  Roberto Ballarin; Mario Spaggiari; Nicola Cautero; Nicola De Ruvo; Roberto Montalti; Cristina Longo; Anna Pecchi; Patrizia Giacobazzi; Giuseppina De Marco; Giuseppe D'Amico; Giorgio Enrico Gerunda; Fabrizio Di Benedetto
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

3.  Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung.

Authors:  Mitchell L Ramsey; Benjamin J Yuh; Matthew T Johnson; Anjana V Yeldandi; Debra L Zynger
Journal:  Virchows Arch       Date:  2011-12-06       Impact factor: 4.064

Review 4.  Defining risk status in the first-line treatment of metastatic renal cell carcinoma.

Authors:  Manuela Schmidinger; Christoph C Zielinski
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-08       Impact factor: 4.553

Review 5.  Long-term management of bilateral, multifocal, recurrent renal carcinoma.

Authors:  Gennady Bratslavsky; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

6.  Genetic architecture of renal cell carcinoma: Do we have to know?

Authors:  Hakan Öztürk
Journal:  World J Urol       Date:  2015-09-28       Impact factor: 4.226

7.  miR-216a-5p acts as an oncogene in renal cell carcinoma.

Authors:  Peijie Chen; Jing Quan; Lu Jin; Canbin Lin; Weijie Xu; Jinling Xu; Xin Guan; Zebo Chen; Liangchao Ni; Shangqi Yang; Yun Chen; Yongqing Lai
Journal:  Exp Ther Med       Date:  2018-02-20       Impact factor: 2.447

Review 8.  Invasion and metastasis of renal cell carcinoma.

Authors:  Shuji Mikami; Mototsugu Oya; Ryuichi Mizuno; Takeo Kosaka; Ken-ichi Katsube; Yasunori Okada
Journal:  Med Mol Morphol       Date:  2013-11-09       Impact factor: 2.309

9.  Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysis.

Authors:  Luise Maute; Viktor Grünwald; Steffen Weikert; Ulrich Kube; Thomas Gauler; Christoph Kahl; Iris Burkholder; Lothar Bergmann
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-21       Impact factor: 4.553

Review 10.  [Recurrent disease in renal cell carcinoma. "Local recurrence" after kidney-sparing and radical resection].

Authors:  M Löhr; D Rohde
Journal:  Urologe A       Date:  2005-04       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.